重组海葵肽类毒素hk2a对慢性充血性心力衰竭新西兰兔左心功能的影响

南方医科大学学报 ›› 2004, Vol. 24 ›› Issue (03): 269-272.

重组海葵肽类毒素hk2a对慢性充血性心力衰竭新西兰兔左心功能的影响

刘彦波¹, 王鹏¹, 欧阳平¹, 许顶立¹, 王磊², 王永华², 梁东², 吴平生¹, 徐安龙²

1. 第一军医大学南方医院心血管内科, 广东, 广州, 510515;
2. 中山大学生命科学院国家高技术计划海洋生物功能基因组开放实验室, 广东广州, 510275

出版日期:2004-03-20 发布日期:2004-03-20
基金资助:
收稿日期:2003-12-24。
基金项目:国家863计划项目(2001AA628090);广州市科委科技攻关引导项目(2002z3-C7111)
作者简介:刘彦波(1975- ),男,医师,第一军医大学在读硕士研究生,电话:020-61364636,E-mail:liuyanbo.cn@163.com
通讯作者:欧阳平,E-mail:ypou@fimmu.com

Effects of a novel recombinant polypeptide from the sea anemone Anthopleura sp. on left ventricular function in New Zealand rabbits with chronic congestive heart failure

LIU Yan-bo¹, WANG Peng¹, OUYANG Ping¹, XU Ding-li¹, WANG Lei², WANG Yong-hua², LIANG Dong², WU Ping-sheng¹, XU An-long²

1. 第一军医大学南方医院心血管内科, 广东, 广州, 510515;
2. 中山大学生命科学院国家高技术计划海洋生物功能基因组开放实验室, 广东广州, 510275

Online:2004-03-20 Published:2004-03-20

摘要/Abstract

摘要： 目的观察重组海葵肽类毒素hk2a对慢性充血性心力衰竭(CCHF)新西兰白兔左心功能的影响。方法采用腹主动脉缩窄术建立新西兰兔CCHF模型,利用超声心动图评价静脉注射hk2a前后不同时段兔左心功能的变化情况,并设立对照组进行比较。结果 hk2a能够在给药后即刻明显增加实验兔的左室射血分数(P<0.05),作用时间持续60 min以上(P<0.05)。与西地兰治疗相比具有起效快、作用强等特点。结论新型海葵肽类毒素hk2a能够明显改善CCHF新西兰兔的左心功能。

Abstract: Objective To observe the effects of recombinant hk2a, a novel neurotoxin from the sea anemone Anthopleura sp. on the left ventricular function in New Zealand rabbits with chronic congestive heart failure(CCHF). Methods CHF model was established using New Zealand rabbits by abdominal aortic coarctation. The left ventricular ejection fraction (LVEF) was measured by Acuson ultrasound systems (Sequoia 512) at 0, 5, 15, 30, 45 and 60 min respectively after intravenous injection with a single dose of recombinant hk2a (20 μg/kg·b.w.). The response of the rabbits to hk2a treatment was observed in comparison with that of the control group. Results Recombinant hk2a immediately and significantly increased the left ventricular ejection fraction of the rabbit models of CCHF after intravenous injection (P<0.05), and its effects were maintained for more than 1 h without affecting the heart rate. Conclusion recombinant hk2a significantly increases the left ventricular ejection fraction in New Zealand rabbits with CCHF.

中图分类号:

R541.61
Q463

刘彦波¹, 王鹏¹, 欧阳平¹, 许顶立¹, 王磊², 王永华², 梁东², 吴平生¹, 徐安龙². 重组海葵肽类毒素hk2a对慢性充血性心力衰竭新西兰兔左心功能的影响[J]. 南方医科大学学报, 2004, 24(03): 269-272.

LIU Yan-bo¹, WANG Peng¹, OUYANG Ping¹, XU Ding-li¹, WANG Lei², WANG Yong-hua², LIANG Dong², WU Ping-sheng¹, XU An-long². Effects of a novel recombinant polypeptide from the sea anemone Anthopleura sp. on left ventricular function in New Zealand rabbits with chronic congestive heart failure[J]. Journal of Southern Medical University, 2004, 24(03): 269-272.

参考文献

[1] 高玉琪,李志樑,吴宏超,等.心力衰竭患者肾上腺髓质素和前体N端20肽的改变[J].第一军医大学学报,2002,22(7):632-4.Gao YQ, Li ZL, Wu HC, et al. Changes of plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide concentrations in patients with heart failure [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(7): 632-4.
[2] 严全能,李志樑,吴宏超,等.慢性心力衰竭患者血浆肾上腺髓质素和cAMP含量的变化及相互关系[J].第一军医大学学报,2002,22(9):803-5.Yan QN, Li ZL, Wu HC, et al. Changes in plasma levels of adreno medullin and cyclic adenosine monophosphate and their interrelation in patients with chronic heart failure [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(9): 803-5.
[3] 钟萍,李志樑,吴宏超,等.充血性心力衰竭患者血浆尾加压素Ⅱ变化的临床研究[J].第一军医大学学报,2003,23(2):121-3.Zhong P, Li ZL, Wu HC, et al. Clinical study of changes ofurotensin Ⅱ in patients with congestive heart failure[J]. J First Mil Med Univ/ Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(2): 121-3.
[4] 刘媛,余细勇,林秋雄,等.充血性心力衰竭患者巨噬细胞移动抑制因子与心功能的相关性[J].第一军医大学学报,2003,23(11):1169-70.Liu Y, Yu XY, Lin QX, et al. Relationship between macrophage mi gration inhibitory factor and cardiac function in patients with congestive heart failure[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(11): 1169-70.
[5] 吕卓人,薛小临,姜馨,等.洋地黄在治疗慢性心力衰竭中地位的再评价[J].中华心血管病杂志,2002,30(3):185-6.Lu ZR, Xue XL, Jiang X, et al. Reevaluation of digitalis therapy in chronic heart failure[J]. Chin J Cardiol, 2002, 30(3): 185-6.
[6] Digitalis Investigation Group. The effect ofdigoxin on mortality and morbidity in patients with heart failure[J]. N Engl J Med, 1997, 336 (8): 525-33.
[7] 黄震华.在心力衰竭治疗中非洋地黄类正性肌力作用药物再评价[J].中国新药与临床杂志,2003,22(5):303-9.Huang ZH. Reappraisal of non-digitalis positive inotropic drugs in treatment of heart failure[J]. Chin J New Drugs Clin Res, 2003, 22 (5): 303-9.
[8] Liu WH, Wang L, Wang YL, et al. Cloning and characterization ora novel neurotoxin from the sea anemone A thopleura sp. [J]. Toxicon, 2003, 41(7): 793-801.
[9] Heller LJ, Opsahl JA, Wernsing SE, et al. Myocardial and plasma rennin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy[J], Am J Physiol, 1998, 274(3pt2): R849-56.
[10] 刘文华,王义良,徐安龙,等.海葵神经毒素基因的克隆和序列分析[J].中国生物化学与分子生物学报,2001,17(5):617-20. Liu WH, Wang YL, Xu AL, et al. Cloning and sequence analysis of neurotoxin gene from sea anemone [J]. Chin J Biochem Molecul Biol, 2001, 17(5): 617-20.
[11] Grors GJ, Warftier DC, Hardman HF, et al. Cardiotonic effects of anthopleurin A (Ap A), a polypeptide from a sea anemone, in dog with a coronary artery stenosis [J]. Eur J Pharmacol, 1985, 110: 271-6.
[12] 傅丽英.海葵毒素的电生理作用[J].现代诊断与治疗(Mod TherTreat),2002,13(1):32-5.
[13] Blair RW, Peterson DF, Bishop VS. The effects of anthopleurin-A on cardiac dynamics in conscious dogs [J]. J Pharmacol Exp Ther, 1978, 207(2): 271-6.
[14] Norton TR. Cardiotonic polypeptides from A nthopleura xanthogrammica (Brandt) and A. elegatissima (Brandt)[J]. Fed Proc, 1981, 40 (1): 21-5.